Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03172624
Title Study of Nivolumab Plus Ipilimumab in Patients With Salivary Gland Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Memorial Sloan Kettering Cancer Center
Indications

adenoid cystic carcinoma

salivary gland cancer

Therapies

Ipilimumab + Nivolumab

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Memoral Sloan Kettering Basking Ridge Basking Ridge New Jersey 07920 United States Details
Memoral Sloan Kettering Monmouth Middletown New Jersey 07748 United States Details
Memorial Sloan Kettering Bergen Montvale New Jersey 07645 United States Details
Memorial Sloan Kettering Commack Commack New York 11725 United States Details
Memorial Sloan Kettering Westchester Harrison New York 10604 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
Memorial Sloan Kettering Rockville Centre Rockville Centre New York 11570 United States Details
Memorial Sloan Kettering Nassau Uniondale New York 11553 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field